Substrates for peptidase M30.001: hyicolysin

Summary Alignment Tree Sequences Sequence features Distribution Literature Substrates

Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.

Substrate Uniprot Residue range Cleavage Site Cleavage type Evidence P4 P3 P2 P1 P1' P2' P3' P4' Reference CutDB MERNUM
glucagon P01274 53-81 His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp+Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr N Lys Tyr Leu Asp Ser Arg Arg Ala Gotz, 2004 17088
glucagon P01274 53-81 His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg+Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr N Asp Ser Arg Arg Ala Gln Asp Phe Gotz, 2004 17089
glucagon P01274 53-81 His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln+Trp-Leu-Met-Asn-Thr N Asp Phe Val Gln Trp Leu Met Asn Gotz, 2004 17090
glucagon P01274 53-81 His-Ser-Gln-Gly-Thr-Phe-Thr-Ser+Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr N Thr Phe Thr Ser Asp Tyr Ser Lys Gotz, 2004 17087
glucagon P01274 53-81 His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys+Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr N Ala Tyr Ser Lys Tyr Leu Asp Ser Gotz, 2004
insulin B-chain (oxidized) P01317 25-54 Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His+Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala N Cya Gly Ser His Leu Val Glu Ala Gotz, 2004
insulin B-chain (oxidized) P01317 25-54 Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr+Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala N Glu Ala Leu Tyr Leu Val Cya Gly Gotz, 2004
insulin B-chain (oxidized) P01317 25-54 Phe-Val-Asn+Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala N - Phe Val Asn Gln His Leu Cya Gotz, 2004
melittin P01501 44-69 Gly-Ile-Gly-Ala-Val-Leu-Lys+Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2 P Ala Val Leu Lys Val Leu Thr Thr Gotz, 2004 17096
melittin P01501 44-69 Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala+Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2 P Gly Leu Pro Ala Leu Ile Ser Trp Gotz, 2004 17097
melittin P01501 44-69 Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg+Lys-Arg-Gln-Gln-NH2 P Trp Ile Lys Arg Lys Arg Gln Gln Gotz, 2004 17101
melittin P01501 44-69 Gly-Ile-Gly-Ala+Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2 P Gly Ile Gly Ala Val Leu Lys Val Gotz, 2004 17095
melittin P01501 44-69 Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu+Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2 P Leu Pro Ala Leu Ile Ser Trp Ile Gotz, 2004 17098
melittin P01501 44-69 Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile+Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2 P Pro Ala Leu Ile Ser Trp Ile Lys Gotz, 2004 17099
melittin P01501 44-69 Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser+Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2 P Ala Leu Ile Ser Trp Ile Lys Arg Gotz, 2004 17100